139 related articles for article (PubMed ID: 2135020)
1. Headache in acromegaly: dramatic improvement with the somatostatin analogue SMS 201-995.
Musolino NR; Marino Júnior R; Bronstein MD
Clin J Pain; 1990 Sep; 6(3):243-5. PubMed ID: 2135020
[TBL] [Abstract][Full Text] [Related]
2. Analgesic effect of octreotide in headache associated with acromegaly is not mediated by opioid mechanisms. Case report.
Pascual J; Freijanes J; Berciano J; Pesquera C
Pain; 1991 Dec; 47(3):341-344. PubMed ID: 1664509
[TBL] [Abstract][Full Text] [Related]
3. [Analgesic effect on headaches of octreotide, a somatostatin analogue, in a case of non-functioning pituitary adenoma].
Turpin G; Foubert L; Noel-Wekstein S; Kujas M; De Gennes JL
Presse Med; 1991 Dec; 20(43):2219-20. PubMed ID: 1838161
[No Abstract] [Full Text] [Related]
4. Truncated somatostatin receptor 5 may modulate therapy response to somatostatin analogues--Observations in two patients with acromegaly and severe headache.
Marina D; Burman P; Klose M; Casar-Borota O; Luque RM; Castaño JP; Feldt-Rasmussen U
Growth Horm IGF Res; 2015 Oct; 25(5):262-7. PubMed ID: 26188991
[TBL] [Abstract][Full Text] [Related]
5. [Analgesic effect of Sandostatin (SMS 201-995) in acromegaly headache].
Sicolo N; Martini C; Ferla S; Roggenkamp J; Vettor R; De Palo C; Federspil G
Minerva Endocrinol; 1990; 15(1):37-42. PubMed ID: 2274013
[TBL] [Abstract][Full Text] [Related]
6. Effect of long-term treatment with somatostatin analogue (SMS 201-995) on pituitary tumor shrinkage in acromegaly--report of two cases.
Mukada K; Uozumi T; Takechi A; Arita K; Yano T; Hirohata T; Onda J; Ohta M
Neurol Med Chir (Tokyo); 1992 Apr; 32(4):215-9. PubMed ID: 1378566
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone rebound after cessation of sms 201-995 treatment in acromegaly.
Charest L; Comtois R; Beauregard H; Serri O
Can J Neurol Sci; 1989 Nov; 16(4):442-5. PubMed ID: 2804808
[TBL] [Abstract][Full Text] [Related]
8. Analgesic effect of the somatostatin analogue octreotide in two acromegalic patients: a double-blind study with long-term follow-up.
Schmidt K; Althoff PH; Harris AG; Prestele H; Schumm-Draeger PM; Usadel KH
Pain; 1993 May; 53(2):223-227. PubMed ID: 8336992
[TBL] [Abstract][Full Text] [Related]
9. [Analgesic effect of a somatostatin analog, SMS 201-995, on headache associated with tumor of the hypophysis].
Webb SM; Cabezas R; Montañés R; de Leiva A
Med Clin (Barc); 1989 Oct; 93(13):501-2. PubMed ID: 2622243
[TBL] [Abstract][Full Text] [Related]
10. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.
Tolis G; Angelopoulos NG; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Protonotariou A; Lytras A
Neuroendocrinology; 2006; 83(3-4):249-57. PubMed ID: 17047390
[TBL] [Abstract][Full Text] [Related]
11. [Octreotide-induced sinus bradycardia in a male patient with acromegaly].
Lima-Martínez MM; López-Méndez G; Mangupli R
Endocrinol Nutr; 2013 Oct; 60(8):e7-9. PubMed ID: 23415777
[No Abstract] [Full Text] [Related]
12. Reduction in sella turcica volume. An effect of long-term treatment with the somatostatin analogue, SMS 201-995, in acromegalic patients.
Lund E; Jørgensen J; Christensen SE; Weeke J; Orskov H; Harris AG
Neuroradiology; 1991; 33(2):162-4. PubMed ID: 2046904
[TBL] [Abstract][Full Text] [Related]
13. Acromegaly and primary amenorrhea: ovulation and pregnancy induced by SMS 201-995 and bromocriptine.
Montini M; Pagani G; Gianola D; Pagani MD; Piolini R; Camboni MG
J Endocrinol Invest; 1990 Feb; 13(2):193. PubMed ID: 2329262
[No Abstract] [Full Text] [Related]
14. Clinical and biochemical effects of incremental doses of the long-acting somatostatin analogue SMS 201-995 in ten acromegalic patients.
Shi YF; Harris AG; Zhu XF; Deng JY
Clin Endocrinol (Oxf); 1990 Jun; 32(6):695-705. PubMed ID: 2200620
[TBL] [Abstract][Full Text] [Related]
15. Effective treatment of recurrent acromegaly with a long-active somatostatin analogue (sandostatin).
Miranda R; Zárate A; Ruíz Velasco G
Arch Invest Med (Mex); 1988; 19(4):445-8. PubMed ID: 3245759
[No Abstract] [Full Text] [Related]
16. Successful treatment of ophthalmoplegia in acromegaly with the somatostatin analogue SMS 201-995.
van Liessum PA; Pieters GF; Hermus AR; Smals AG; Kloppenborg PW
Neth J Med; 1988 Jun; 32(5-6):289-92. PubMed ID: 2899298
[No Abstract] [Full Text] [Related]
17. The analgesic effect and development of dependency to somatostatin analogue (octreotide) in headache associated with acromegaly.
Popovic V; Paunovic VR; Micic D; Nesovic M; Kendereski A; Djordjevic P; Manojlovic D; Micic J
Horm Metab Res; 1988 Apr; 20(4):250-1. PubMed ID: 2899539
[No Abstract] [Full Text] [Related]
18. [Outcome of somatostatin analogue treatment in acromegaly].
Mondok A; Tóth M; Patócs A; Szücs N; Igaz P; Pusztai P; Czirják S; Beko G; Gláz E; Rácz K; Tulassay Z
Orv Hetil; 2009 Aug; 150(31):1457-62. PubMed ID: 19617182
[TBL] [Abstract][Full Text] [Related]
19. Another case where bigger is not better.
Weber KT
Cardiovasc Res; 1997 Oct; 36(1):1-2. PubMed ID: 9415265
[No Abstract] [Full Text] [Related]
20. NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut.
Gorden P; Comi RJ; Maton PN; Go VL
Ann Intern Med; 1989 Jan; 110(1):35-50. PubMed ID: 2535688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
